HB 2801
bill letting schools stock epinephrine nasal sprays
Died in committee
Verdict: No flags
Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
Caption
relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.
Caption from analyzed text · version I.
Summary
Auto-injectors get company. Same training, same liability shield.
The bill swaps the term "epinephrine auto-injector" for a broader "epinephrine delivery device" throughout the school stock-epinephrine law, and defines that term to include any FDA-approved device that delivers epinephrine for anaphylaxis, including nasal sprays. It touches public school districts, charter schools, private schools, colleges, prescribers, pharmacists and the school staff and volunteers trained to give the medicine. Schools that keep emergency epinephrine can stock and use nasal sprays as well as auto-injectors, under the same training, reporting, standing-order and liability-shield rules as before.
Labels
Labels: NEVER GOT A HEARING. Filed Feb 13, 2025 and referred to the House Public Education committee. No public hearing. The bill died.
Receipt
The receipt
89R-HB2801 · 2025-02-13
SOLD BY
ITEM
relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.
WHAT IT DOES
Auto-injectors get company. Same training, same liability shield.
The bill swaps the term "epinephrine auto-injector" for a broader "epinephrine delivery device" throughout the school stock-epinephrine law, and defines that term to include any FDA-approved device that delivers epinephrine for anaphylaxis, including nasal sprays. It touches public school districts, charter schools, private schools, colleges, prescribers, pharmacists and the school staff and volunteers trained to give the medicine. Schools that keep emergency epinephrine can stock and use nasal sprays as well as auto-injectors, under the same training, reporting, standing-order and liability-shield rules as before.
CHARGES
[ ] NONE FOUND
TOTAL
No fiscal note in the loaded record.
HISTORY
- Filed
- Read first time
- Referred to Public Education
FILED UNDER
THE TEXT
“"Epinephrine delivery device" means a medical delivery device approved by the United States Food and Drug Administration that delivers a dose of epinephrine intended for use to treat anaphylaxis, including:”
Bill text, introduced version (I)
The bill widens the school prescription channel for stock epinephrine to cover any FDA-approved delivery device, including nasal sprays, still obtained by prescription and standing order.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
CAMPAIGN PAID FOR BY
Donors
Not tied to this bill.
Sources
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Oct 27, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Texas Organizing Project Political Action Committee$17,454.66
Texas Organizing Project Political Action Committee
$17,454.66
- Cash
- $0.00
- Paid by others
- $17,454.66
- Total
- $17,454.66
Also funds 4 other sitting lawmakers.
Derived recipient stock · Sep 30, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.
TEC account match.
Sources
Derived itemized flow · Oct 2, 2026 to Oct 22, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101072739.
Texas Trial Lawyers Association PAC$15,000.00
Texas Trial Lawyers Association PAC
$15,000.00
- Cash
- $15,000.00
- Paid by others
- $0.00
- Total
- $15,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 10, 2024 to Oct 16, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986942, 101031959, 101060742, 101072739.
Texas Sands PAC$12,000.00
Texas Sands PAC
$12,000.00
- Cash
- $12,000.00
- Paid by others
- $0.00
- Total
- $12,000.00
Also funds 121 other sitting lawmakers.
Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 10, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986942, 101060742, 101072739.
Missing data does not establish zero giving. Display amounts are rounded.
Texas Organizing Project Political Action Committee
$17,454.66
- Cash
- $0.00
- Paid by others
- $17,454.66
- Total
- $17,454.66
Also funds 4 other sitting lawmakers.
Derived recipient stock · Sep 30, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.
TEC account match.
Sources
Derived itemized flow · Oct 2, 2026 to Oct 22, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101072739.
Texas Trial Lawyers Association PAC
$15,000.00
- Cash
- $15,000.00
- Paid by others
- $0.00
- Total
- $15,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 10, 2024 to Oct 16, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986942, 101031959, 101060742, 101072739.
Texas Sands PAC
$12,000.00
- Cash
- $12,000.00
- Paid by others
- $0.00
- Total
- $12,000.00
Also funds 121 other sitting lawmakers.
Derived recipient stock · Jul 3, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 10, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100986942, 101060742, 101072739.
Votes
No floor vote loaded for this bill.
Fiscal
No fiscal note in the loaded record.
How this was graded
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Sources
Texas House · Filed Feb 13, 2025
03/19/2025 H Referred to Public Education: Mar 19 2025 12:35PM
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:19 AM CDT. Grades, charges, quotes and corrections follow the published record.
House committee · Public Education · Final status: Died in committee
Subjects
Education--Primary & Secondary--General
Health--Other Diseases & Medical Conditions
Minors--Health & Safety
MEDICINE & PRESCRIPTION DRUGS
EDUCATION, COMMISSIONER OF
HEALTH & HUMAN SERVICES COMMISSION
STATE HEALTH SERVICES, DEPARTMENT OF
Text
The text as introduced · 1,957 words
89R10397 RAL-D By: Simmons H.B. No. 2801 A BILL TO BE ENTITLED AN ACT relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 38.0151(f), Education Code, is amended to read as follows: (f) A school district or open-enrollment charter school that provides for the maintenance, administration, and disposal of epinephrine delivery devices [ auto-injectors ] under Subchapter E is not required to comply with this section. SECTION 2. The heading to Subchapter E, Chapter 38, Education Code, is amended to read as follows: SUBCHAPTER E. MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE DELIVERY DEVICES [ AUTO-INJECTORS ] AND MEDICATION FOR RESPIRATORY DISTRESS SECTION 3. Section 38.201, Education Code, is amended by amending Subdivision (3-a) and adding Subdivision (3-b) to read as follows: (3-a) "Epinephrine delivery device" means a medical delivery device approved by the United States Food and Drug Administration that delivers a dose of epinephrine intended for use to treat anaphylaxis, including: (A) an epinephrine auto-injector; and (B) an epinephrine nasal spray. (3-b) "Medication for respiratory distress" means albuterol, levalbuterol, or another medication designated by the executive commissioner of the Health and Human Services Commission for treatment of respiratory distress under Section 38.208(c). SECTION 4. Section 38.202(a), Education Code, is amended to read as follows: (a) The commissioner of state health services shall establish an advisory committee to examine and review the administration, on a campus of a school district, an open-enrollment charter school, a private school, or an institution of higher education, of: (1) epinephrine delivery devices [ auto-injectors ] to a person experiencing an anaphylactic reaction; and (2) medication for respiratory distress to a person experiencing respiratory distress. SECTION 5. Section 38.207, Education Code, is amended to read as follows: Sec. 38.207. ADVISORY COMMITTEE: DUTIES. The advisory committee shall advise the commissioner of state health services on: (1) the storage and maintenance of epinephrine delivery devices [ auto-injectors ] and medication for respiratory distress on school campuses and campuses of institutions of higher education; (2) the training of school personnel and school volunteers, and of personnel and volunteers at institutions of higher education, in the administration of an epinephrine delivery device [ auto-injector ]; (3) the training of school personnel and school volunteers, and of personnel and volunteers at institutions of higher education, in the administration of a medication for respiratory distress; and (4) a plan for: (A) one or more school personnel members or school volunteers trained in the administration of an epinephrine delivery device [ auto-injector ] to be on each school campus; (B) one or more school personnel members or school volunteers trained in the administration of medication for respiratory distress to be on each school campus; (C) one or more personnel members or volunteers of an institution of higher education trained in the administration of an epinephrine delivery device [ auto-injector ] to be on each campus of an institution of higher education; and (D) one or more personnel members or volunteers of an institution of higher education trained in the administration of medication for respiratory distress to be on each campus of an institution of higher education. SECTION 6. The heading to Section 38.208, Education Code, is amended to read as follows: Sec. 38.208. MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE DELIVERY DEVICES [ AUTO-INJECTORS ] AND MEDICATION FOR RESPIRATORY DISTRESS. SECTION 7. Sections 38.208(a), (b), (c), (d), (d-2), and (e), Education Code, are amended to read as follows: (a) Each school district, open-enrollment charter school, and private school may adopt and implement a policy regarding the maintenance, administration, and disposal of epinephrine delivery devices [ auto-injectors ] at each campus in the district or school. (b) If a policy is adopted under Subsection (a), the policy: (1) must provide that school personnel and school volunteers who are authorized and trained may administer an epinephrine delivery device [ auto-injector ] to a person who is reasonably believed to be experiencing anaphylaxis on a school campus; and (2) may provide that school personnel and school volunteers who are authorized and trained may administer an epinephrine delivery device [ auto-injector ] to a person who is reasonably believed to be experiencing anaphylaxis at an off-campus school event or while in transit to or from a school event. (c) The executive commissioner of the Health and Human Services Commission, in consultation with the commissioner of education, and with advice from the advisory committee as appropriate, shall adopt rules regarding the maintenance, administration, and disposal of an epinephrine delivery device [ auto-injector ] at a school campus subject to a policy adopted under Subsection (a) and the maintenance, administration, and disposal of medication for respiratory distress at a school campus subject to a policy adopted under Subsection (a-1). The rules must establish: (1) the number of epinephrine delivery devices [ auto-injectors ] available at each campus; (2) the amount of medication for respiratory distress available at each campus; (3) the process for each school district, open-enrollment charter school, and private school to check the inventory of epinephrine delivery devices [ auto-injectors ] and medication for respiratory distress at regular intervals for expiration and replacement; (4) the amount of training required for school personnel and school volunteers to administer: (A) an epinephrine delivery device [ auto-injector ]; or (B) medication for respiratory distress; and (5) the types of medication that may be administered under Subsection (b-1) to persons experiencing respiratory distress, based on a review of the best available medical evidence. (d) Each school district, open-enrollment charter school, and private school that adopts a policy under Subsection (a) must require that each campus have one or more school personnel members or school volunteers authorized and trained to administer an epinephrine delivery device [ auto-injector ] present during all hours the campus is open. (d-2) A school personnel member or school volunteer may not be subject to any penalty or disciplinary action for refusing to administer or receive training to administer epinephrine delivery devices [ auto-injectors ] or medication for respiratory distress, as applicable, in accordance with a policy adopted under Subsection (a) or (a-1). (e) The supply of epinephrine delivery devices [ auto-injectors ] at each campus must be stored in a secure location and be easily accessible to school personnel and school volunteers authorized and trained to administer an epinephrine delivery device [ auto-injector ]. SECTION 8. Section 38.209, Education Code, is amended to read as follows: Sec. 38.209. REPORT ON ADMINISTERING EPINEPHRINE DELIVERY DEVICE [ AUTO-INJECTOR ]. (a) Not later than the 10th business day after the date a school personnel member or school volunteer administers an epinephrine delivery device [ auto-injector ] in accordance with a policy adopted under Section 38.208(a), the school shall report the information required under Subsection (b) to: (1) the school district, the charter holder if the school is an open-enrollment charter school, or the governing body of the school if the school is a private school; (2) the physician or other person who prescribed the epinephrine delivery device [ auto-injector ]; and (3) the commissioner of state health services. (b) The report required under this section must include the following information: (1) the age of the person who received the administration of the epinephrine delivery device [ auto-injector ]; (2) whether the person who received the administration of the epinephrine delivery device [ auto-injector ] was a student, a school personnel member or school volunteer, or a visitor; (3) the physical location where the epinephrine delivery device [ auto-injector ] was administered; (4) the number of doses of epinephrine [ auto-injector ] administered; (5) the title of the person who administered the epinephrine delivery device [ auto-injector ]; and (6) any other information required by the commissioner of education. SECTION 9. Section 38.210(a), Education Code, is amended to read as follows: (a) Each school district, open-enrollment charter school, and private school that adopts a policy under Section 38.208(a) is responsible for training school personnel and school volunteers in the administration of an epinephrine delivery device [ auto-injector ]. The training must include information on: (1) recognizing the signs and symptoms of anaphylaxis; (2) administering an epinephrine delivery device [ auto-injector ]; (3) implementing emergency procedures, if necessary, after administering an epinephrine delivery device [ auto-injector ]; and (4) properly disposing of used or expired epinephrine delivery devices [ auto-injectors ]. SECTION 10. The heading to Section 38.211, Education Code, is amended to read as follows: Sec. 38.211. PRESCRIPTION OF EPINEPHRINE DELIVERY DEVICES [ AUTO-INJECTORS ] AND MEDICATION FOR RESPIRATORY DISTRESS. SECTION 11. Sections 38.211(a), (b), (c), (e), and (f), Education Code, are amended to read as follows: (a) A physician or person who has been delegated prescriptive authority under Chapter 157, Occupations Code, may prescribe epinephrine delivery devices [ auto-injectors ] or medication for respiratory distress in the name of a school district, open-enrollment charter school, or private school. (b) A physician or other person who prescribes epinephrine delivery devices [ auto-injectors ] or medication for respiratory distress under Subsection (a) shall provide the school district, open-enrollment charter school, or private school with a standing order for the administration of, as applicable: (1) an epinephrine delivery device [ auto-injector ] to a person reasonably believed to be experiencing anaphylaxis; or (2) medication for respiratory distress to a person reasonably believed to be experiencing respiratory distress. (c) The standing order under Subsection (b) is not required to be patient-specific, and the epinephrine delivery device [ auto-injector ] or medication for respiratory distress may be administered to a person without a previously established physician-patient relationship. (e) An order issued under this section must contain: (1) the name and signature of the prescribing physician or other person; (2) the name of the school district, open-enrollment charter school, or private school to which the order is issued; (3) as applicable, the quantity and types of epinephrine delivery devices [ auto-injectors ] or the quantity and types of medications for respiratory distress to be obtained and maintained under the order; and (4) the date of issue. (f) A pharmacist may dispense an epinephrine delivery device [ auto-injector ] or medication for respiratory distress to a school district, open-enrollment charter school, or private school without requiring the name or any other identifying information relating to the user. SECTION 12. Section 38.215(a), Education Code, is amended to read as follows: (a) A person who in good faith takes, or fails to take, any action under this subchapter is immune from civil or criminal liability or disciplinary action resulting from that action or failure to act, including: (1) issuing an order for epinephrine delivery devices [ auto-injectors ] or medication for respiratory distress; (2) supervising or delegating the administration of an epinephrine delivery device [ auto-injector ] or medication for respiratory distress; (3) possessing, maintaining, storing, or disposing of an epinephrine delivery device [ auto-injector ] or medication for respiratory distress; (4) prescribing an epinephrine delivery device [ auto-injector ] or medication for respiratory distress; (5) dispensing: (A) an epinephrine delivery device [ auto-injector ]; or (B) medication for respiratory distress; (6) administering, or assisting in administering, an epinephrine delivery device [ auto-injector ] or medication for respiratory distress; (7) providing, or assisting in providing, training, consultation, or advice in the development, adoption, or implementation of policies, guidelines, rules, or plans; or (8) undertaking any other act permitted or required under this subchapter. SECTION 13. This Act takes effect immediately if it receives a vote of two-thirds of all the members elected to each house, as provided by Section 39, Article III, Texas Constitution. If this Act does not receive the vote necessary for immediate effect, this Act takes effect September 1, 2025.